Cefoperazone sodium impregnated polycaprolactone composite implant for osteomyelitis

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 4, 2009, Pages 377-381

  Anand, A ^a   Pundir, R ^a   Pandian, C S ^a   Saraf, S ^a   Gupta, H ^b  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Biodegradable implants; Calcium sulphate; Cefoperazone sodium; Osteomyelitis; Polycaprolactone

Indexed keywords

CALCIUM SULFATE; CEFOPERAZONE; POLYCAPROLACTONE;

ARTICLE; BIODEGRADABLE IMPLANT; COMPOSITE MATERIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG IMPLANT; DRUG RELEASE; DRUG SOLUTION; HARDNESS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSTEOMYELITIS; TENSILE STRENGTH;

EID: 71049176218     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.57285     Document Type: Article

References (25)

1. Marks KE, Nelson CL, Lautenschlager EP. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg Am 1976;58:358-364
2. Murray WR. Use of antibiotic-containing bone cement. Clin Orthop Relat Res 1984;190:89-95.
3. Wahllg H, Dingeldein E, Buchholz MW, Buchholz M, Bachmann F. Pharmacokinetic study of gentamicin-loaded cement in total hip replacements: comparative effects of varying dosage. J Bone Joint Surg Br 1984;66:175-179
4. Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic impregnated implant. J Ortho Surg 2002;10:53-60.
5. Hanseen AD. Local antibiotic delivery vehicle in the treatment of musculoskeletal infection. Session IV. Clin Orthop Relat Res 2005;437:91-96
6. Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: Current concepts. Clin Orthop Relat Res 1984;190:96-108.
7. Kirkpatrick DK, Von Fraunhofer JA, Trachtenberg IS, Seligson D, Mangino PD. In vitro characteristics of tobramycin-PMMA beads: Compressive strength and leaching. Orthopedics 1985;8:1130-1133
8. Vaudaux PE, Zulian G, Huggler E, Waldvogel FA. Attachment of staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. Infect Immunol 1985;50:472-477
9. Salvati EA, Callaghan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection: Elution of gentamicin from cement and beads. Clin Orthop Relat Res 1986;207:83-93.
10. Baker AS, Greenham LW. Release of gentamicin from acrylic bone cement: Elution and diffusion studies. J Bone Joint Surg Am 1988;70:155l-7.
11. Gao C, Gao J, You X, Huo S, Li X, Zhang Y, et al. Fabrication of calcium sulfate/PLLA composite for bone Repair. J Biomed Mat Res Part A 2005;73:244-253
12. Walsh D, Furuzono T, Tanaka J. Preparation of porous composite implant materials by in situ polymerization of porous apatite containing å-caprolactone or methyl methacrylate. Biomaterial 2001;22:1205-1212
13. Laurencin CT, Ambrosio AM, Borden MD, Cooper JA Jr. Tissue engineering: Orthopaedic applications. Ann Rev Biomed Eng 1999;1:19-46.
14. Orsini G, Ricci J, Scarano A, Pecora G, Petrone G, Piattelli A. Bone- defect healing with calcium-sulfate particles and cement: An experimental study in rabbit. J Biomed Mat Res B App Biomaterial 2004;68:199-208.
15. Ziran BH, Smith WR, Morgan SJ. Use of calcium-based demineralized bone matrix/allograft for nonunions and posttraumatic reconstruction of the appendicular skeleton: Preliminary results and complications. J Trauma 2007;62:1324-1328
16. Harris RJ. Clinical evaluation of a composite bone graft with a calcium sulfate barrier. J Periodontology 2004;75:685-692
17. Gatta AL, Rosa AD, Laurienzo P, Malinconico M, Rosa MD, Schiraldi C. A novel injectable poly (epsilon-caprolactone)/calcium sulfate system for bone regeneration: Synthesis and characterization. Macromol Biosci 2005;5:1108-1117
18. Chunjuan G, Shujuan H, Xiulan L, Xiudong Y, Yang Z, Jianping G. Characteristics of calcium sulfate/gelatin composite biomaterials for bone repair. J Biomat Sci Polymer Edition 2007;18:799-824.
19. Agrawal CM, Ray RB. Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. J Biomed Mat Res 2001;55:141-150
20. Mano JF, Sousa RA, Boesel LF, Neves NM, Reis RL. Bioinert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: State of the art and recent developments. Comp Sci Technol 2004;64:789-817.
21. Overbeck JP, Winckler ST, Meffert R, Törmälä P, Spiegel HU, Brug E. Penetration of ciprofloxacin into bone: A new bioabsorbable implant. J Invest 1995;8:155-162
22. Ramchandani M, Robinson D, In vitro in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Rel 1998;54:167-175
23. Désévaux C, Lenaerts V, Girard C, Dubreuil P. Characterization of crosslinked high amylase starch matrix implants: In vivo release of ciprofloxacin. J Control Release 2002;82:95-103. (Pubitemid 34775051)
24. Désévaux C, Lenaerts V, Girard C, Dubreuil P. Characterization of crosslinked high amylase starch matrix implants: In vitro release of ciprofloxacin. J Control Release 2002;82:83-93. (Pubitemid 34775050)
25. El-Kamel AH, Baddour MM. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: In vitro and in vivo evaluation. Drug Deliv 2007;14:349-356